Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony Cutts

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Bioinformatics (Oxford, England)|July 30, 2020
A statistical approach for tracking clonal dynamics in cancer using longitudinal next-generation sequencing dataDimitrios V Vavoulis, Anthony Cutts, Jenny C Taylor, et al.
European Journal of Cancer (Oxford, England : 1990)|July 24, 2025
Circulating tumour DNA to augment PET-CT in determining clinical outcome after head and neck cancer treatmentSumrit Bola, Anthony Cutts, Dimitris Vavoulis, et al.
NPJ Genomic Medicine|October 28, 2017
Characterisation of the changing genomic landscape of metastatic melanoma using cell free DNAAnthony Cutts, Oliver Venn, Alexander Dilthey, et al.
JCO Global Oncology|January 9, 2025
Targeted Next-Generation Sequencing of Cell-Free DNA to Detect <i>MYC</i>-Immunoglobulin Translocation and Epstein-Barr Virus DNA in Plasma of Burkitt Lymphoma Patients in East AfricaClara Chamba, Daisy Jennings, Rehema Shungu, et al.
British Journal of Cancer|December 17, 2019
Dual-specificity protein phosphatase DUSP4 regulates response to MEK inhibition in BRAF wild-type melanomaAvinash Gupta, Christopher Towers, Frances Willenbrock, et al.
Plos One|September 15, 2016
Targeted Next-Generation Sequencing of Plasma DNA from Cancer Patients: Factors Influencing Consistency with Tumour DNA and Prospective Investigation of Its Utility for DiagnosisPamela J Kaisaki, Anthony Cutts, Niko Popitsch, et al.
Plos Medicine|February 15, 2017
Clinical applicability and cost of a 46-gene panel for genomic analysis of solid tumours: Retrospective validation and prospective audit in the UK National Health ServiceAngela Hamblin, Sarah Wordsworth, Jilles M Fermont, et al.
Nature Communications|January 8, 2025
Multimodal cell-free DNA whole-genome TAPS is sensitive and reveals specific cancer signalsDimitrios V Vavoulis, Anthony Cutts, Nishita Thota, et al.
Nature Medicine|March 20, 2026
Liquid biopsy for the diagnosis of EBV-positive Burkitt's lymphoma in endemic areasClara Chamba, Heavenlight Christopher, Emmanuel Josephat, et al.
Nature Genetics|November 5, 2022
Whole-genome sequencing of chronic lymphocytic leukemia identifies subgroups with distinct biological and clinical featuresPauline Robbe, Kate E Ridout, Dimitrios V Vavoulis, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Bioinformatics (Oxford, England)|July 30, 2020
A statistical approach for tracking clonal dynamics in cancer using longitudinal next-generation sequencing dataDimitrios V Vavoulis, Anthony Cutts, Jenny C Taylor, et al.
European Journal of Cancer (Oxford, England : 1990)|July 24, 2025
Circulating tumour DNA to augment PET-CT in determining clinical outcome after head and neck cancer treatmentSumrit Bola, Anthony Cutts, Dimitris Vavoulis, et al.
NPJ Genomic Medicine|October 28, 2017
Characterisation of the changing genomic landscape of metastatic melanoma using cell free DNAAnthony Cutts, Oliver Venn, Alexander Dilthey, et al.
JCO Global Oncology|January 9, 2025
Targeted Next-Generation Sequencing of Cell-Free DNA to Detect <i>MYC</i>-Immunoglobulin Translocation and Epstein-Barr Virus DNA in Plasma of Burkitt Lymphoma Patients in East AfricaClara Chamba, Daisy Jennings, Rehema Shungu, et al.
British Journal of Cancer|December 17, 2019
Dual-specificity protein phosphatase DUSP4 regulates response to MEK inhibition in BRAF wild-type melanomaAvinash Gupta, Christopher Towers, Frances Willenbrock, et al.
Plos One|September 15, 2016
Targeted Next-Generation Sequencing of Plasma DNA from Cancer Patients: Factors Influencing Consistency with Tumour DNA and Prospective Investigation of Its Utility for DiagnosisPamela J Kaisaki, Anthony Cutts, Niko Popitsch, et al.
Plos Medicine|February 15, 2017
Clinical applicability and cost of a 46-gene panel for genomic analysis of solid tumours: Retrospective validation and prospective audit in the UK National Health ServiceAngela Hamblin, Sarah Wordsworth, Jilles M Fermont, et al.
Nature Communications|January 8, 2025
Multimodal cell-free DNA whole-genome TAPS is sensitive and reveals specific cancer signalsDimitrios V Vavoulis, Anthony Cutts, Nishita Thota, et al.
Nature Medicine|March 20, 2026
Liquid biopsy for the diagnosis of EBV-positive Burkitt's lymphoma in endemic areasClara Chamba, Heavenlight Christopher, Emmanuel Josephat, et al.
Nature Genetics|November 5, 2022
Whole-genome sequencing of chronic lymphocytic leukemia identifies subgroups with distinct biological and clinical featuresPauline Robbe, Kate E Ridout, Dimitrios V Vavoulis, et al.
Pageof 1